Madrigal Pharmaceuticals
MDGL
MDGL
140 hedge funds and large institutions have $1.2B invested in Madrigal Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 45 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
3% less funds holding
Funds holding: 144 → 140 (-4)
16% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 25
41% less call options, than puts
Call options by funds: $9.34M | Put options by funds: $15.7M
Holders
140
Holding in Top 10
5
Calls
$9.34M
Puts
$15.7M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$28.1M | |
| 3 | +$18.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$16.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.06M |
Top Sellers
| 1 | -$41.2M | |
| 2 | -$14.3M | |
| 3 | -$5.58M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.87M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.23M |